Dr. Jasmeet S. Assi, M.D.
Pathology (Anatomic Pathology & Clinical Pathology Physician)
- Medicare participating
At a glance
- Years since graduation
- 15
- In the NPI registry since
- 2015
- Medicare patients seen, 2024
- 253
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Anatomic Pathology & Clinical Pathology Physician primary
KS license 04-44797
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Kansas Hospital Kansas City, KS
- University of Kansas Health System Olathe Hospital Olathe, KS
Medical groups
- University of Kansas Hospital Authority (250 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 253
- Services billed
- 1,029
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Pathology examination of tissue using a microscope, intermediate complexity | 376 | 187 |
| Special stained specimen slides to examine tissue, each additional procedure | 247 | 78 |
| Microscopic genetic analysis of tumor, using computer-assisted technology | 160 | 41 |
| Special stained specimen slides to examine tissue, initial procedure | 157 | 112 |
| Evaluation of fine needle aspirate with interpretation and report | 144 | 91 |
| Cell examination of specimen, selective cellular enhancement technique | 127 | 114 |
| Pathology examination of tissue using a microscope, moderately high complexity | 101 | 50 |
| Pathology examination of specimen during surgery, first tissue block | 45 | 20 |
| Microscopic genetic analysis of tumor, manual | 42 | 22 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 33 | 33 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $36.07 in total to this clinician.
| Roche Diagnostics Corporation | $36.07 |
|---|
| Food and Beverage | $36.07 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.